LLY News and Press, Eli Lilly and Company From 02/16/24

2024-02-16 12:34:51 ET More on Viking Therapeutics Viking Therapeutics, Inc. (VKTX) Q4 2024 Earnings Call Transcript Evaluating Viking's Position In The GLP-1/GIP Agonist Race Biotech And Pharma Diversification Pays Off Viking Therapeutics GAAP EPS of -$0.25 ...

2024-02-16 10:29:22 ET More on Novartis Novartis And MorphoSys Are A Perfect Match Novartis AG (NVS) Q4 2023 Earnings Call Transcript Novartis AG 2023 Q4 - Results - Earnings Call Presentation MorphoSys ADRs gain after definitive merger agreement with Novarti...

2024-02-16 08:30:00 ET Summary Novo Nordisk investors have witnessed significant growth and outperformed the S&P 500, but the recent surge has led to considerable overvaluation. The company remains the market leader in the GLP-1 market, benefiting from the surge in demand amid...

2024-02-16 07:15:34 ET More on Eli Lilly Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Eli Lilly: Overvaluation Is A Big Red Flag Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly obesity therapy tirzepatide being rolled out in...

2024-02-15 14:03:45 ET Summary Eli Lilly's financial results for Q4 2023 showed a 28% increase in total revenue compared to the same period last year. The company's new launch, Zepbound, is expected to drive sales growth in 2024 and contribute to a projected revenue growth of 18-2...

2024-02-15 11:45:00 ET Today, just seven publicly listed companies are valued at a market cap of more than US$1 trillion. However, the widening GDP (gross domestic product) rates globally and expanding earnings base for corporates should drive valuations in the upcoming decade. Here...

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.3% to $4.3 on volume of 124,140,302 shares Treasure Global Inc. (TGL) rose 60.4% to $0.1588 on volume of 122,843,335 shares PROSHARES TRUST (SQQQ) fell 3.3% to $11.41 on volume...

2024-02-15 08:45:06 ET Palm Beach, FL – February 15, 2024 – FN Media Group News Commentary – Numerous reports indicate that the fibromyalgia treatment market is positioned to continue to grow at a substantial rate through the next decade. Fibromyalgia is a chronic c...

2024-02-15 07:53:06 ET More on Eli Lilly Eli Lilly: Overvaluation Is A Big Red Flag Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade) Eli Lilly partner BioAge wins $170M t...

2024-02-14 17:35:57 ET Summary Novo Nordisk reported great results for fiscal 2023 with the top and bottom line growing in the higher double-digits. Growth was especially driven by Wegovy and Ozempic, and management is also optimistic for fiscal 2024. Novo Nordisk is trading f...